Latest news on coronavirus. The modern vaccine arrived in Italy. Ema, Astrazeneca requested marketing authorization, decision of 29



[ad_1]

Remuzzi (director Mario Negri), would be at the service of the Italian production site

By countering Covid “we are doing well, because there are already three safe and effective vaccines, and many more will arrive soon.” But without extra effort, “it is not certain that it will end well, at least in the short term.” He says this in an interview with Corriere della Sera Professor Giuseppe Remuzzi, director of the Mario Negri Institute in Milan. Even when they work, “the masked enclosures and different colored areas are still an admission of failure in the fight against the virus. Instead, the vaccine is the solution. Along with natural immunity, but no one can say when it will arrive, he explains. We are vaccinating 400,000 people a week. Let’s even imagine reaching 700,000. It is not enough. “If in Italy things turned out” as they are in England or Germany, we run the risk of a thousand deaths a day. “The goal of reaching 50 million vaccinated people by the end of March” is utopian. But we have the We must believe that it is possible. And then we need a medium-term strategy. “We must extend” the agreement that AstraZeneca has made with the Serum Institute of India to other companies, and bring together all the production plants in the world. “Together,” billions of doses can be made and a plan entrusted to WHO and international vaccine organizations would allow the vaccine to reach where it is most needed. “With respect,” I ask myself: but in this discussion about the ESM, isn’t there between 2 and 3 billion to allocate to an Italian site capable of producing vaccines? “. For the director of Negri, being only” financiers and buyers, and not producers in the strict sense, puts us in a weak position compared to others “. If the EMA approves A strazeneca, “in Italy we would approach 15 million doses in the next few months.” But “I’m not sure that’s enough.” For Remuzzi, it would be better “to vaccinate a large number of people with a single dose than a small sample with two doses. It can be assumed that the withdrawal will not take place before 120 days have passed. However, the level of protection induced by the first dose of the vaccine is very high.

[ad_2]